In the News
Guest Blog Post #8: Facilitating shared decision-making about deprescribing: The perspective of patients, pharmacists and GPs
Hello deprescribers, welcome to our 8th guest blog post. Today we have Dr. Kristie Weir from the University of Sydney summarizing key findings from her recent Ph.D. dissertation that explored preferences around communication and decision-making in deprescribing....
Guest Blog Post #7: To deprescribe or not to deprescribe: Considerations in older adults with polypharmacy during the COVID-19 pandemic
Welcome to our 7th guest blog post. Today, we have Dr. Nagham J. Ailabouni from the University of South Australia writing about deprescribing during the COVID-19 pandemic. Take it away! COVID-19 and older adults The coronavirus disease (COVID-19) pandemic has affected...
Guest Blog Post #6: DeprescrIPP: Deprescribing proton pump inhibitors in primary care
Hello deprescribing world! Today we have another guest blog post by Dr. Jean-Pascal Fournier and Dr. Jerome Nguyen from Nantes University in France. Today, they will tell us about a deprescribing study they are currently working on. DeprescrIPP The department of...
Guest Blog Post #5: Deprescribing, Polypharmacy and Aging from an Anthropological Perspective
Hi everyone, this week we will have another guest blog post. Today we have Dr. Sofie Rosenlund Lau (MScPharm, PhD in medical anthropology) discussing how anthropology and ethnography can be used in deprescribing research and to facilitate deprescribing in clinical...
Guest Blog Post #4: Meaningful Measurement Matters!
Hi everyone, welcome to our fourth guest blog post. Today we will have Dr. Ashley Martinez (PharmD, PhD) from the University of Kentucky summarizing her recent PhD dissertation – and discussing medication appropriateness measurement tools to meaningfully identify...